Cargando…
Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine
AIM: To investigate whether duodenal lesions induced by major venous occlusions can be attenuated by BPC 157 regardless nitric oxide (NO) system involvement. METHODS: Male Wistar rats underwent superior anterior pancreaticoduodenal vein (SAPDV)-ligation and were treated with a bath at the ligated SA...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305534/ https://www.ncbi.nlm.nih.gov/pubmed/30598581 http://dx.doi.org/10.3748/wjg.v24.i47.5366 |
_version_ | 1783382587424636928 |
---|---|
author | Amic, Fedor Drmic, Domagoj Bilic, Zdenko Krezic, Ivan Zizek, Helena Peklic, Marina Klicek, Robert Pajtak, Alen Amic, Enio Vidovic, Tinka Rakic, Mislav Milkovic Perisa, Marija Horvat Pavlov, Katarina Kokot, Antonio Tvrdeic, Ante Boban Blagaic, Alenka Zovak, Mario Seiwerth, Sven Sikiric, Predrag |
author_facet | Amic, Fedor Drmic, Domagoj Bilic, Zdenko Krezic, Ivan Zizek, Helena Peklic, Marina Klicek, Robert Pajtak, Alen Amic, Enio Vidovic, Tinka Rakic, Mislav Milkovic Perisa, Marija Horvat Pavlov, Katarina Kokot, Antonio Tvrdeic, Ante Boban Blagaic, Alenka Zovak, Mario Seiwerth, Sven Sikiric, Predrag |
author_sort | Amic, Fedor |
collection | PubMed |
description | AIM: To investigate whether duodenal lesions induced by major venous occlusions can be attenuated by BPC 157 regardless nitric oxide (NO) system involvement. METHODS: Male Wistar rats underwent superior anterior pancreaticoduodenal vein (SAPDV)-ligation and were treated with a bath at the ligated SAPDV site (BPC 157 10 μg, 10 ng/kg per 1 mL bath/rat; L-NAME 5 mg/kg per 1 mL bath/rat; L-arginine 100 mg/kg per 1 mL bath/rat, alone and/or together; or BPC 157 10 μg/kg instilled into the rat stomach, at 1 min ligation-time). We recorded the vessel presentation (filled/appearance or emptied/disappearance) between the 5 arcade vessels arising from the SAPDV on the ventral duodenum side, the inferior anterior pancreaticoduodenal vein (IAPDV) and superior mesenteric vein (SMV) as bypassing vascular pathway to document the duodenal lesions presentation; increased NO- and oxidative stress [malondialdehyde (MDA)]-levels in duodenum. RESULTS: Unlike the severe course in the SAPDV-ligated controls, after BPC 157 application, the rats exhibited strong attenuation of the mucosal lesions and serosal congestion, improved vessel presentation, increased interconnections, increased branching by more than 60% from the initial value, the IAPDV and SMV were not congested. Interestingly, after 5 min and 30 min of L-NAME and L-arginine treatment alone, decreased mucosal and serosal duodenal lesions were observed; their effect was worsened at 24 h, and no effect on the collateral vessels and branching was seen. Together, L-NAME+L-arginine antagonized each other’s response, and thus, there was an NO-related effect. With BPC 157, all SAPDV-ligated rats receiving L-NAME and/or L-arginine appeared similar to the rats treated with BPC 157 alone. Also, BPC 157 in SAPDV-ligated rats normalized levels of NO and MDA, two oxidative stress markers, in duodenal tissues. CONCLUSION: BPC 157, rapidly bypassing occlusion, rescued the original duodenal flow through IAPDV to SMV flow, an effect related to the NO system and reduction of free radical formation. |
format | Online Article Text |
id | pubmed-6305534 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-63055342018-12-31 Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine Amic, Fedor Drmic, Domagoj Bilic, Zdenko Krezic, Ivan Zizek, Helena Peklic, Marina Klicek, Robert Pajtak, Alen Amic, Enio Vidovic, Tinka Rakic, Mislav Milkovic Perisa, Marija Horvat Pavlov, Katarina Kokot, Antonio Tvrdeic, Ante Boban Blagaic, Alenka Zovak, Mario Seiwerth, Sven Sikiric, Predrag World J Gastroenterol Basic Study AIM: To investigate whether duodenal lesions induced by major venous occlusions can be attenuated by BPC 157 regardless nitric oxide (NO) system involvement. METHODS: Male Wistar rats underwent superior anterior pancreaticoduodenal vein (SAPDV)-ligation and were treated with a bath at the ligated SAPDV site (BPC 157 10 μg, 10 ng/kg per 1 mL bath/rat; L-NAME 5 mg/kg per 1 mL bath/rat; L-arginine 100 mg/kg per 1 mL bath/rat, alone and/or together; or BPC 157 10 μg/kg instilled into the rat stomach, at 1 min ligation-time). We recorded the vessel presentation (filled/appearance or emptied/disappearance) between the 5 arcade vessels arising from the SAPDV on the ventral duodenum side, the inferior anterior pancreaticoduodenal vein (IAPDV) and superior mesenteric vein (SMV) as bypassing vascular pathway to document the duodenal lesions presentation; increased NO- and oxidative stress [malondialdehyde (MDA)]-levels in duodenum. RESULTS: Unlike the severe course in the SAPDV-ligated controls, after BPC 157 application, the rats exhibited strong attenuation of the mucosal lesions and serosal congestion, improved vessel presentation, increased interconnections, increased branching by more than 60% from the initial value, the IAPDV and SMV were not congested. Interestingly, after 5 min and 30 min of L-NAME and L-arginine treatment alone, decreased mucosal and serosal duodenal lesions were observed; their effect was worsened at 24 h, and no effect on the collateral vessels and branching was seen. Together, L-NAME+L-arginine antagonized each other’s response, and thus, there was an NO-related effect. With BPC 157, all SAPDV-ligated rats receiving L-NAME and/or L-arginine appeared similar to the rats treated with BPC 157 alone. Also, BPC 157 in SAPDV-ligated rats normalized levels of NO and MDA, two oxidative stress markers, in duodenal tissues. CONCLUSION: BPC 157, rapidly bypassing occlusion, rescued the original duodenal flow through IAPDV to SMV flow, an effect related to the NO system and reduction of free radical formation. Baishideng Publishing Group Inc 2018-12-21 2018-12-21 /pmc/articles/PMC6305534/ /pubmed/30598581 http://dx.doi.org/10.3748/wjg.v24.i47.5366 Text en ©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Basic Study Amic, Fedor Drmic, Domagoj Bilic, Zdenko Krezic, Ivan Zizek, Helena Peklic, Marina Klicek, Robert Pajtak, Alen Amic, Enio Vidovic, Tinka Rakic, Mislav Milkovic Perisa, Marija Horvat Pavlov, Katarina Kokot, Antonio Tvrdeic, Ante Boban Blagaic, Alenka Zovak, Mario Seiwerth, Sven Sikiric, Predrag Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine |
title | Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine |
title_full | Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine |
title_fullStr | Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine |
title_full_unstemmed | Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine |
title_short | Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine |
title_sort | bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide bpc 157, l-name and l-arginine |
topic | Basic Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305534/ https://www.ncbi.nlm.nih.gov/pubmed/30598581 http://dx.doi.org/10.3748/wjg.v24.i47.5366 |
work_keys_str_mv | AT amicfedor bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine AT drmicdomagoj bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine AT biliczdenko bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine AT krezicivan bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine AT zizekhelena bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine AT peklicmarina bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine AT klicekrobert bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine AT pajtakalen bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine AT amicenio bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine AT vidovictinka bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine AT rakicmislav bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine AT milkovicperisamarija bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine AT horvatpavlovkatarina bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine AT kokotantonio bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine AT tvrdeicante bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine AT bobanblagaicalenka bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine AT zovakmario bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine AT seiwerthsven bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine AT sikiricpredrag bypassingmajorvenousocclusionandduodenallesionsinratsandtherapywiththestablegastricpentadecapeptidebpc157lnameandlarginine |